The Association of Body Mass Index and 20-Year All-Cause Mortality Among Patients With Stable Coronary Artery Disease.
Bezafibrate
/ therapeutic use
Body Mass Index
Cause of Death
/ trends
Coronary Artery Disease
/ etiology
Female
Follow-Up Studies
Forecasting
Humans
Hypolipidemic Agents
/ therapeutic use
Israel
/ epidemiology
Male
Middle Aged
Obesity
/ complications
Population Surveillance
Prospective Studies
Registries
Survival Rate
/ trends
All-cause mortality
BMI
Long-term outcomes
Obesity
Prognosis
Stable coronary artery disease
Journal
Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
20
05
2017
revised:
19
12
2017
accepted:
18
02
2018
pubmed:
28
3
2018
medline:
13
4
2019
entrez:
28
3
2018
Statut:
ppublish
Résumé
Limited data exist regarding the long-term association of body mass index (BMI) and all-cause mortality among patients with stable coronary artery disease (CAD). Accordingly, the aim of this study is to explore the association between BMI and long-term all-cause mortality among patients with stable CAD. Our study included 15,357 patients with stable CAD who were enrolled in the Bezafibrate Infarction Prevention (BIP) registry between February, 1990 and October1992, and subsequently followed-up through December 2014. 5,051 (33%) patients were classified as normal weight (BMI 18.5-24.99kg/m Our findings indicate that obesity is independently associated with increased risk for long-term mortality among patients with stable coronary artery disease, whereas overweight does not appear to confer an additional risk in this population.
Sections du résumé
BACKGROUND
BACKGROUND
Limited data exist regarding the long-term association of body mass index (BMI) and all-cause mortality among patients with stable coronary artery disease (CAD). Accordingly, the aim of this study is to explore the association between BMI and long-term all-cause mortality among patients with stable CAD.
METHODS
METHODS
Our study included 15,357 patients with stable CAD who were enrolled in the Bezafibrate Infarction Prevention (BIP) registry between February, 1990 and October1992, and subsequently followed-up through December 2014.
RESULTS
RESULTS
5,051 (33%) patients were classified as normal weight (BMI 18.5-24.99kg/m
CONCLUSIONS
CONCLUSIONS
Our findings indicate that obesity is independently associated with increased risk for long-term mortality among patients with stable coronary artery disease, whereas overweight does not appear to confer an additional risk in this population.
Identifiants
pubmed: 29581037
pii: S1443-9506(18)30078-7
doi: 10.1016/j.hlc.2018.02.015
pii:
doi:
Substances chimiques
Hypolipidemic Agents
0
Bezafibrate
Y9449Q51XH
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
719-726Informations de copyright
Copyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.